Sinus laser therapy versus sinus lay open in the management of sacrococcygeal pilonidal disease.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 19 05 2021
received: 03 01 2021
accepted: 19 05 2021
pubmed: 28 5 2021
medline: 5 10 2021
entrez: 27 5 2021
Statut: ppublish

Résumé

There is no standard method for the management of sacrococcygeal pilonidal disease (SPND); however, surgery remains the gold standard treatment. Wide surgical excision of the sinus is the traditional surgical treatment of SPND, yet it is associated with extended healing time and delayed recovery. This study aimed to compare the outcomes of sinus laser therapy (SiLaT) and sinus lay open in the management of SPND. Patients with SPND who were treated with SiLaT or lay open were retrospectively reviewed. The main outcome measures were the success of surgery in terms of complete healing at 12 months postoperatively, time to complete healing, complications, operation time and quality of life (QoL). A total of 139 patients with a mean age of 25 years were included to the study. Sixty-two patients underwent SiLaT and 77 underwent lay open. Six patients experienced recurrence after SiLaT while there was no recorded recurrence after the lay open technique (P = 0.007). Sinus lay open had a shorter operation time than SiLaT (P < 0.0001). On the other hand, SiLaT was followed by a shorter healing time, lower incidence of delayed wound healing, better cosmetic outcome, and higher QoL scores compared to the lay open group. The complication rates were comparable between the two groups. Sinus lay open was associated with better success than SiLaT. On the other hand, SiLaT was associated with quicker healing, better cosmesis, better QoL and longer operation time. The complication rate of the two procedures was comparable.

Identifiants

pubmed: 34042233
doi: 10.1111/codi.15755
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2456-2465

Informations de copyright

© 2021 The Association of Coloproctology of Great Britain and Ireland.

Références

Mahmood F, Hussain A, Akingboye A. Pilonidal sinus disease: review of current practice and prospects for endoscopic treatment. Ann Med Surg. 2020;57:212-7.
Bendewald FP, Cima RR. Pilonidal disease. Clin Colon Rectal Surg. 2007;20(2):86-95.
Iesalnieks I, Ommer A. The management of pilonidal sinus. Dtsch Arztebl Int. 2019;116(1-2):12-21.
Nixon AT, Garza RF. Pilonidal cyst and sinus. [Updated 2020 Aug 10]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020. [cited 2020 Aug]. Available from https://www.ncbi.nlm.nih.gov/books/NBK557770
Johnson EK, Vogel JD, Cowan ML, Feingold DL, Steele SR, Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons’ Clinical Practice Guidelines for the Management of Pilonidal Disease. Dis Colon Rectum. 2019;62(2):146-57.
Dogru O, Camci C, Aygen E, Girgin M, Topuz O. Pilonidal sinus treated with crystallized phenol: an eight-year experience. Dis Colon Rectum. 2004;47(11):1934-8.
Kaymakcioglu N, Yagci G, Simsek A, Unlu A, Tekin OF, Cetiner S, et al. Treatment of pilonidal sinus by phenol application and factors affecting the recurrence. Tech Coloproctol. 2005;9(1):21-4.
Seleem MI, Al-Hashemy AM. Management of pilonidal sinus using fibrin glue: a new concept and preliminary experience. Colorectal Dis. 2005;7(4):319-22.
Lund J, Tou S, Doleman B, Williams JP. Fibrin glue for pilonidal sinus disease. Cochrane Database Syst Rev. 2017;1:CD011923.
Elbanna HG, Emile SH, Youssef M, Thabet W, El-Hamed TM, Ghnnam WM. Novel approach of treatment of pilonidal sinus disease with thrombin gelatin matrix as a sealant. Dis Colon Rectum. 2016;59(8):775-80. https://doi.org/10.1097/DCR.0000000000000604
Sevinç B, Damburacı N, Karahan Ö. Long term results of minimally invasive treatment of pilonidal disease by platelet rich plasma. J Visc Surg. 2020;157(1):33-5.
Al-Khamis A, McCallum I, King PM, Bruce J. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2010;2010(1):CD006213.
Emir S, Topuz O, Kanat BH, Bali I. Sinotomy technique versus surgical excision with primary closure technique in pilonidal sinus disease. Bosn J Basic Med Sci. 2014;14(4):263-7.
Nelson J, Billingham R. Pilonidal disease and hidradenitis suppurativa. In: The ASCRS Textbook of Colon and Rectal Surgery. New York, NY: Springer, 2007; p. 228-39.
Stauffer VK, Luedi MM, Kauf P, Schmid M, Diekmann M, Wieferich K, et al. Common surgical procedures in pilonidal sinus disease: a meta-analysis, merged data analysis, and comprehensive study on recurrence. Sci Rep. 2018;8(1):3058.
Emile SH, Elfeki H, Shalaby M, Sakr A, Giaccaglia V, Sileri P, et al. Endoscopic pilonidal sinus treatment: a systematic review and meta-analysis. Surg Endosc. 2018;32(9):3754-62. https://doi.org/10.1007/s00464-018-6157-5
Pappas AF, Christodoulou DK. A new minimally invasive treatment of pilonidal sinus disease with the use of a diode laser: a prospective large series of patients. Colorectal Dis. 2018;20(8):O207-O214.
Guner A, Cekic AB, Boz A, Turkyilmaz S, Kucuktulu U. A proposed staging system for chronic symptomatic pilonidal sinus disease and results in patients treated with stage-based approach. BMC Surg. 2016;16(16):18.
Tezel E. A new classification according to navicular area concept for sacrococcygeal pilonidal disease. Colorectal Dis. 2007;9(6):575-6.
Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-33.
Item Short Form Survey from the RAND Medical Outcomes Study [Internet]. Rand.org. 2020. [cited 2020 Oct]. Available from: https://www.rand.org/health-care/surveys_tools/mos/12-item-short-form.html
Free online SF-12 score calculator-OrthoToolKit [Internet]. Orthotoolkit.com. 2020. [cited 2020 Oct 5]. Available from: https://www.orthotoolkit.com/sf-12/
Garg P, Garg M, Gupta V, Mehta SK, Lakhtaria P. Lay open (deroofing) and curettage under local anesthesia for pilonidal disease: an outpatient procedure. World J Gastrointest Surg. 2015;7(9):214-8.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
Abdelnaby M, Emile SH, El-Said M, AbdelMawla A, Elgendy H, Sakr A, et al. Rotational gluteal flap versus modified Limberg flap in treatment of sacrococcygeal pilonidal disease. J Surg Res. 2018;223:174-82. https://doi.org/10.1016/j.jss.2017.11.017
Ertan T, Koc M, Gocmen E, Aslar AK, Keskek M, Kilic M. Does technique alter quality of life after pilonidal sinus surgery? Am J Surg. 2005;190(3):388-92.
Urhan MK, Kücükel F, Topgul K, Ozer I, Sari S. Rhomboid excision and Limberg flap for managing pilonidal sinus: results of 102 cases. Dis Colon Rectum. 2002;45(5):656-9.
Arnous M, Elgendy H, Thabet W, Emile SH, Elbaz SA, Khafagy W. Excision with primary midline closure compared with Limberg flap in the treatment of sacrococcygeal pilonidal disease: a randomised clinical trial. Ann R Coll Surg Engl. 2019;101(1):21-9.
Ritchie H, Roser M. Obesity [Internet]. Our World in Data, 2020. [cited 2020 Oct 6]. Available from https://ourworldindata.org/obesity
WHO. Global status report on noncommunicable diseases: 2014. Geneva: World Health Organization, 2015; p. 203.
Harlak A, Mentes O, Kilic S, Coskun K, Duman K, Yilmaz F. Sacrococcygeal pilonidal disease: analysis of previously proposed risk factors. Clinics (Sao Paulo). 2010;65(2):125-31.
Dessily M, Dziubeck M, Chahidi E, Simonelli V. The SiLaC procedure for pilonidal sinus disease: long-term outcomes of a single institution prospective study. Tech Coloproctol. 2019;23(12):1133-40. https://doi.org/10.1007/s10151-019-02119-2

Auteurs

Mahmoud Abdelnaby (M)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Mohammad Fathy (M)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Sameh Hany Emile (SH)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Mohamed Arnous (M)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Mohamed Balata (M)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Ahmed Abdelmawla (A)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Emad Abdallah (E)

General Surgery Department, Mansoura University Hospitals, Mansoura University, Mansoura, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH